Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B

被引:74
作者
Kondo, Yasuteru
Kobayashi, Koju
Ueno, Yoshiyuki
Shiina, Masaaki
Niitsuma, Hirofumi
Kanno, Noriatsu
Kobayashi, Tomoo
Shimosegawa, Tooru
机构
[1] Tohoku Univ, Sch Hlth Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan
[2] Sendai Med Ctr, Dept Gastroenterol, Miyagino Ku, Sendai, Miyagi 9830045, Japan
[3] Furukawa City Hosp, Dept Internal Med, Senjujimae, Furukawa 9196183, Japan
关键词
hepatitis B virus; regulatory T cells; IL-10; FOXP3; TH1;
D O I
10.3748/wjg.v12.i27.4310
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study the mechanisms of hyporesponsiveness of HBV-specific CD4(+) T cells by testing TH1 and TH2 commitment and regulatory T cells. METHODS: Nine patients with chronic hepatitis B were enrolled. Peripheral blood mononuclear cells were stimulated with HBcAg or HBsAg to evaluate their potential to commit to TH1 and TH2 differentiation. HBcAg-specific activity of regulatory T cells was evaluated by staining with antibodies to CD4, CD25, CTLA-4 and interleukin-10. The role of regulatory T cells was further assessed by treatment with anti-interleukin-10 antibody and depletion of CD4(+)CD25(+) cells. RESULTS: Level of mRNAs for T-bet, IL-12R beta 2 and IL-4 was significantly lower in the patients than in healthy subjects with HBcAg stimulation. Although populations of CD4(+)CD25(high)CTLA-4(+) T cells were not different between the patients and healthy subjects, IL-10 secreting cells were found in CD4+ cells and CD4+CD25+ cells in the patients in response to HBcAg, and they were not found in cells which were stimulated with HBsAg. Addition of anti-IL-10 antibody recovered the amount of HBcAg-specific TH1 antibody compared with control antibody (P <0.01, 0.34% +/- 0.12% vs 0.15% +/- 0.04%). Deletion of CD4+CD25+ T cells increased the amount of HBcAg-specific TH1 antibody when compared with lymphocytes reconstituted using regulatory T cells (P < 0.01, 0.03% +/- 0.02% vs 0.18% +/- 0.05%). CONCLUSION: The results indicate that the mechanism of T cell hyporesponsiveness to HBcAg includes activation of HBcAg-induced regulatory T cells in contrast to an increase in TH2-committed cells in response to HBsAg. (C) 2006 The WIG Press. All rights reserved.
引用
收藏
页码:4310 / 4317
页数:8
相关论文
共 41 条
[1]
Real-time quantitative polymerase chain reaction - A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies [J].
Aarskog, NK ;
Vedeler, CA .
HUMAN GENETICS, 2000, 107 (05) :494-498
[2]
Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420515, 10.1172/JCI200420415]
[3]
Antiviral T-cell responses and therapy in chronic hepatitis B [J].
Alatrakchi, N ;
Koziel, MJ .
JOURNAL OF HEPATOLOGY, 2003, 39 (04) :631-634
[4]
Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression [J].
Beilharz, MW ;
Sammels, LM ;
Paun, A ;
Shaw, K ;
van Eeden, P ;
Watson, MW ;
Ashdown, ML .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4917-4925
[5]
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy [J].
Boni, C ;
Penna, A ;
Ogg, GS ;
Bertoletti, A ;
Pilli, M ;
Cavallo, C ;
Cavalli, A ;
Urbani, S ;
Boehme, R ;
Panebianco, R ;
Fiaccadori, F ;
Ferrari, C .
HEPATOLOGY, 2001, 33 (04) :963-971
[6]
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B [J].
Boni, C ;
Bertoletti, A ;
Penna, A ;
Cavalli, A ;
Pilli, M ;
Urbani, S ;
Scognamiglio, P ;
Boehme, R ;
Panebianco, R ;
Fiaccadori, F ;
Ferrari, C .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :968-975
[7]
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B [J].
Boni, C ;
Penna, A ;
Bertoletti, A ;
Lamonaca, V ;
Rapti, I ;
Missale, G ;
Pilli, M ;
Urbani, S ;
Cavalli, A ;
Cerioni, S ;
Panebianco, R ;
Jenkins, J ;
Ferrari, C .
JOURNAL OF HEPATOLOGY, 2003, 39 (04) :595-605
[8]
CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis [J].
Boyer, O ;
Saadoun, D ;
Abriol, J ;
Dodille, M ;
Piette, JC ;
Cacoub, P ;
Klatzmann, D .
BLOOD, 2004, 103 (09) :3428-3430
[9]
An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection [J].
Cabrera, R ;
Tu, ZK ;
Xu, YL ;
Firpi, RJ ;
Rosen, HR ;
Liu, C ;
Nelson, DR .
HEPATOLOGY, 2004, 40 (05) :1062-1071
[10]
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886